Abstract:Glioblastoma is the most common malignant primary brain tumor, and it is one of the causes of cancer fatality in both adult and pediatric populations. Patients with glioblastoma require chemotherapy after surgical resection and radiotherapy. Therefore, chemotherapy constitutes a viable approach for the eradication of glioblastoma cells. In this study, the anti-tumor activity of sinomenine hydrochloride (SH) was evaluated in U87 and SF767 cells in vitro and in vivo. The results showed that SH potently inhibited U87 and SF767 cell viability and did not cause caspase-dependent cell death, as demonstrated by the absence of significant early apoptosis and caspase-3 cleavage. Instead, SH activated an autophagy-mediated cell death pathway, as indicated by the accumulated microtubule-associated protein light chain 3B (LC3B)-II, triggered autophagic flux and enhanced cell viability after pretreatment with autophagy inhibitors. SH-mediated autophagy in the two cell lines was implicated in reactive oxygen species (ROS) generation, protein kinase B (Akt)-mammalian target of rapamycin (mTOR) pathway suppression and c-Jun NH2-terminal kinase (JNK) pathway activation. The ROS antioxidant N-acetylcysteine (NAC), the Akt-specific activator insulin-like growth factor-1 (IGF-1) and the JNK-specific inhibitor SP600125 attenuated SH-induced autophagy. Moreover, ROS activated autophagy via the Akt-mTOR and JNK pathways. Additionally, SH treatment may promote lysosome biogenesis through activating transcription factor EB (TFEB). The in vivo study found that SH effectively suppressed glioblastoma growth without exhibiting significant toxicity. In conclusion, our findings reveal a novel mechanism of action of SH in cancer cells via the induction of autophagy through ROS generation and autophagy-lysosome pathway activation; these findings also supply a new potential therapeutic agent for the treatment of human glioblastoma.

A Novel Selenadiazole Derivative Induces Apoptosis in Human Glioma Cells by Dephosphorylation of AKT

Microwave-Assisted Syntheses of Benzimidazole-Containing Selenadiazole Derivatives That Induce Cell-Cycle Arrest and Apoptosis in Human Breast Cancer Cells by Activation of the ROS/AKT Pathway.

The Novel Benzothiazole Derivative PB11 Induces Apoptosis via the PI3K/AKT Signaling Pathway in Human Cancer Cell Lines

Synthesis of Selenazolopyridine Derivatives with Capability to Induce Apoptosis in Human Breast Carcinoma MCF-7 Cells Through Scavenge of Intracellular ROS.

Caspase- and P53-Dependent Apoptosis in Breast Carcinoma Cells Induced by a Synthetic Selenadiazole Derivative

Mitochondria-mediated apoptosis in human breast carcinoma MCF-7 cells induced by a novel selenadiazole derivative.

Sodium Selenite Induces Apoptosis Via ROS‐mediated NF‐κB Signaling and Activation of the Bax–caspase‐9–caspase‐3 Axis in 4T1 Cells

Sensitization of Cancer Cells to Radiation by Selenadiazole Derivatives by Regulation of ROS-mediated DNA Damage and ERK and AKT Pathways.

Novel tetrahydroquinoline derivatives induce ROS-mediated apoptosis in glioblastoma cells

Highly Stable Selenadiazole Derivatives Induce Bladder Cancer Cell Apoptosis and Inhibit Cell Migration and Invasion Through the Activation of ROS-mediated Signaling Pathways

1,4-Diselenophene-1,4-diketone Triggers Caspase-Dependent Apoptosis in Human Melanoma A375 Cells Through Induction of Mitochondrial Dysfunction

Synthesis, Anticancer Activity of a Novel Selenadiazole Derivative and Its Interaction with Bovine Serum Albumin

Novel 1,3,4-Selenadiazole Containing Kidney-Type Glutaminase Inhibitors Showed Improved Cellular Uptake and Antitumor Activity.

Selenadiazole Derivatives Antagonize Hyperglycemia-Induced Drug Resistance in Breast Cancer Cells by Activation of AMPK Pathways.

Synthesis and Biological Activity of Novel Organoselenium Derivatives Targeting Multiple Kinases and Capable of Inhibiting Cancer Progression to Metastases

Sinomenine Hydrochloride Inhibits Human Glioblastoma Cell Growth Through Reactive Oxygen Species Generation and Autophagy-Lysosome Pathway Activation: an in Vitro and in Vivo Study.

A Novel Water-Soluble Benzothiazole Derivative BD926 Triggers ROS-mediated B Lymphoma Cell Apoptosis Via Mitochondrial and Endoplasmic Reticulum Signaling Pathways.

Seleno-Podophyllotoxin Derivatives Induce Hepatoma Smmc-7721 Cell Apoptosis Through Bax Pathway

Rational Design of Cancer-Targeted Benzoselenadiazole by Rgd Peptide Functionalization for Cancer Theranostics

Novel 1,8-Naphthalimide Derivatives Inhibit Growth and Induce Apoptosis in Human Glioblastoma

2‐Methoxy‐5((3,4,5‐trimethosyphenyl) Seleninyl) Phenol Causes G2/M Cell Cycle Arrest and Apoptosis in NSCLC Cells Through Mitochondrial Apoptotic Pathway and MDM2 Inhibition